Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Barrera

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Medwave|December 30, 2017
Is flumazenil an alternative for the treatment of hepatic encephalopathy?Diego Reyes, Francisco Barrera
Case Reports in Endocrinology|July 19, 2019
Poorly Controlled Type 3c Diabetes due to Use of Veterinarian Insulin SyringesFrancisco Barrera, Natia Murvelashvili
Clinics in Liver Disease|November 27, 2013
The role of diet and nutritional intervention for the management of patients with NAFLDFrancisco Barrera, Jacob George
Hepatology (Baltimore, Md.)|June 22, 2013
Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?Francisco Barrera, Jacob George
Annals of Hepatology|March 24, 2010
Shortened therapy for genotype 1 hepatitis C virus. The final answer?Francisco Barrera M, Alejandro Soza
Annals of Hepatology|April 13, 2015
Obeticholic acid: expanding the therapeutic landscape of NASHMarco Arrese, Daniel Cabrera, Francisco Barrera
Seminars in Thrombosis and Hemostasis|June 7, 2015
Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?Francisco Barrera, Pamela Zúñiga, Marco Arrese
Salud Publica De Mexico|April 25, 2018
[[Resistance profile of uropathogens in patients with diabetes in Quito, Ecuador, a disturbing panorama]]Fernando Gordillo-Altamirano, Francisco Barrera-Guarderas
Annals of Hepatology|October 29, 2017
Bile Acids and Portal HypertensionJuan Pablo Arab, Francisco Barrera, Marco Arrese
Annals of Hepatology|June 15, 2019
Bile Acids and Portal HypertensionJuan Pablo Arab, Francisco Barrera, Marco Arrese
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Medwave|December 30, 2017
Is flumazenil an alternative for the treatment of hepatic encephalopathy?Diego Reyes, Francisco Barrera
Case Reports in Endocrinology|July 19, 2019
Poorly Controlled Type 3c Diabetes due to Use of Veterinarian Insulin SyringesFrancisco Barrera, Natia Murvelashvili
Clinics in Liver Disease|November 27, 2013
The role of diet and nutritional intervention for the management of patients with NAFLDFrancisco Barrera, Jacob George
Hepatology (Baltimore, Md.)|June 22, 2013
Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?Francisco Barrera, Jacob George
Annals of Hepatology|March 24, 2010
Shortened therapy for genotype 1 hepatitis C virus. The final answer?Francisco Barrera M, Alejandro Soza
Annals of Hepatology|April 13, 2015
Obeticholic acid: expanding the therapeutic landscape of NASHMarco Arrese, Daniel Cabrera, Francisco Barrera
Seminars in Thrombosis and Hemostasis|June 7, 2015
Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?Francisco Barrera, Pamela Zúñiga, Marco Arrese
Salud Publica De Mexico|April 25, 2018
[[Resistance profile of uropathogens in patients with diabetes in Quito, Ecuador, a disturbing panorama]]Fernando Gordillo-Altamirano, Francisco Barrera-Guarderas
Annals of Hepatology|October 29, 2017
Bile Acids and Portal HypertensionJuan Pablo Arab, Francisco Barrera, Marco Arrese
Annals of Hepatology|June 15, 2019
Bile Acids and Portal HypertensionJuan Pablo Arab, Francisco Barrera, Marco Arrese
Pageof 10